Over 10 years experience of Traceability Solutions
By pharmatrax
Category: Technoloy
No Comments
The healthcare sector has been perhaps the slowest of all industries to embrace digitisation — and in fewer countries is this more evident than in…
By pharmatrax
Category: Technoloy
No Comments
At the HIMSS Connected Health Conference, Bob Coughlin, president and CEO of Mass Biotech Council, offers his expert view of how these two areas of…
By pharmatrax
Category: Technoloy
No Comments
The advances in Artificial intelligence (AI) have effectively proliferated into numerous sectors, for example, computer vision, speech recognition and natural language processing. Artificial intelligence is…
By pharmatrax
Category: Technoloy
No Comments
A study that identified 12 novel compounds that may prove valuable against new drug targets for leishmaniasis and Chagas disease was not without complication. Here,…
By pharmatrax
Category: Technoloy
No Comments
The identification and synthesis of molecules for new medicines could soon be undertaken in a lab where decisions are made by artificial intelligence, an advance…
By pharmatrax
Category: Technoloy
No Comments
As precision medicine hones its skills and attempts to become even more personalized, pharma companies and clinical trial designs must embrace new strategies. Be sure…
By pharmatrax
Category: Technoloy
No Comments
The Cool Chain Association (CCA) brings together leaders and professionals from across the cool chain industry to network, share insights and trial new ideas at its…
By pharmatrax
Category: Technoloy
No Comments
Hu-manity.co and other firms want to help people monetize their own medical info, but the potential market raises plenty of ethical concerns for civil liberties…
By pharmatrax
Category: Technoloy
No Comments
Under regulatory pressure, a large number of pharmaceutical manufacturers, shippers and wholesalers are adopting blockchain to track and trace prescription drugs. The pharmaceutical industry in…
By pharmatrax
Category: Technoloy
No Comments
For the first time, a Toronto-based company called Deep Genomics has discovered a drug target and corresponding candidate using artificial intelligence (AI). The company announced…